摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-2-vinylcyclohexanol | 29108-24-5

中文名称
——
中文别名
——
英文名称
trans-2-vinylcyclohexanol
英文别名
2-Ethenylcyclohexan-1-ol
trans-2-vinylcyclohexanol化学式
CAS
29108-24-5
化学式
C8H14O
mdl
——
分子量
126.199
InChiKey
CEBPBNSXJDTCPS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    70-71.5 °C(Press: 14 Torr)
  • 密度:
    0.9422 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    trans-2-vinylcyclohexanol3-氯-2-甲基丙烯 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 反应 0.08h, 以85%的产率得到
    参考文献:
    名称:
    利用Ni-NHC和γ-配位的协同作用在环异构化中合成中等规模的杂环
    摘要:
    本文介绍了一种过渡金属催化中型杂环的不对称环异构化的新方法。一个NHC-NIH催化剂和γ -杂原子螯合的空间和电子效应作为1的基础,一起使用Ñ -二烯末端分化和Ñ γ -外型- TRIG(头-尾)产物选择性。由相应的1,n通过微调NHC的特性获得-Dienes。在竞争实验中进一步证明了潜在假设的含义,在该竞争实验中,优先形成应变的oxepines,而不是其他竞争的oxa /碳环素。在更苛刻的物理条件下和使用合适的NHC配体,在一个罐中将环外亚甲基产物进一步异构化为区域内环烯烃产物。
    DOI:
    10.1021/jo5008477
  • 作为产物:
    描述:
    2-氯环己酮乙烯基溴化镁氢化铝锂 以67%的产率得到
    参考文献:
    名称:
    HOLT A. D., TETRAHEDRON LETT., 1981, 22, NO 24, 2243-2246
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS
    申请人:Meyer Imke
    公开号:US20130137710A1
    公开(公告)日:2013-05-30
    The present invention relates to the cosmetic, dermatological or therapeutic use of certain cyclohexyl carbamate compounds of formula (I) given below, preferably as anti-cellulite actives. The invention further relates to compositions and cosmetic, dermatological or therapeutic products comprising such compounds of formula (I), which are preferably suitable for the prophylaxis (prevention) and cosmetic treatment (combating) of cellulite in human beings, corresponding methods and novel compounds of formula (I) wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl, wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms, B denotes NR 1 R 2 , wherein R 1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R 2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R 1 and R 2 are covalently bonded to one another, preferably so that B is a 3 to 8 membered ring.
    本发明涉及以下式子(I)所示的某些环己基氨基甲酸酯化合物的化妆品、皮肤科或治疗用途,优选作为抗脂肪纹活性剂。本发明还涉及包含该式(I)化合物的组合物和化妆品、皮肤科或治疗产品,这些化合物优选用于人类的脂肪纹预防和美容治疗,以及相应的方法和新型式(I)化合物。其中,A表示......,X、Y和Z分别独立地表示氢、C1-C4烷基或C2-C4烯基,其中可选地,X、Y和Z中的两个基团彼此共价结合形成二环环系统,在这样的二环环系统中,X、Y和Z中的两个基团一起优选形成具有1至4个碳原子的基团,优选为具有1至3个碳原子的碳氢基团,B表示NR1R2,其中R1表示氢或具有1至14个碳原子的有机基团,R2表示具有1至14个碳原子的有机基团,可选地,R1和R2彼此共价结合,优选使得B为3至8个成员的环。
  • Cyclohexyl carbamate compounds as anti-ageing actives
    申请人:Symrise AG
    公开号:EP2389922A1
    公开(公告)日:2011-11-30
    The present invention relates to the cosmetic, dermatological or therapeutic use of compounds of formula (I) given below, in particular as anti-ageing actives. wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl, wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms, B denotes NR1R2, wherein R1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R1 and R2 are covalently bonded to one another, preferably so that B is a 3 to 8 membered ring. The invention further relates to corresponding methods and to compositions and cosmetic, dermatological or pharmaceutical preparations (compositions) comprising one or more compounds of formula (I) and one or more further anti-ageing actives. The invention further relates to compounds of formula (I) as a drug, their use for the preparation of a pharmaceutical composition and to certain novel compounds of formula (I).
    本发明涉及以下式子(I)的化合物在化妆品、皮肤科或治疗中的使用,特别是作为抗衰老活性物质。 其中, A代表 其中,X、Y和Z分别独立地表示氢、C1-C4烷基或C2-C4烯基, 其中,可选地,X、Y和Z中的两个基团在形成二环环系的同时共价键合在一起,这样,在这样的二环环系中,X、Y和Z中的两个基团一起优选形成具有1到4个碳原子的基团,优选是指1到3个碳原子的碳氢基团, B代表NR1R2, 其中, R1代表氢或具有1到14个碳原子的有机基团, R2代表具有1到14个碳原子的有机基团, 并且可选地,R1和R2共价键合在一起,优选是使B成为3到8成员环。 本发明还涉及相应的方法、包含一个或多个式(I)化合物和一个或多个进一步的抗衰老活性物质的组合物和化妆品、皮肤科或制药制剂(组合物)。本发明还涉及式(I)化合物作为药物、其用于制备制药组合物以及某些新的式(I)化合物。
  • STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
    申请人:Scott Ian Leslie
    公开号:US20120129860A1
    公开(公告)日:2012-05-24
    The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.
    本发明通常涉及用于治疗神经退行性疾病和障碍的组合物和方法,特别是用于治疗眼科疾病和障碍。本文提供了包括但不限于苯乙烯衍生物化合物和含有这些化合物的组合物,这些化合物对于治疗和预防眼科疾病和障碍,包括年龄相关性黄斑退化(AMD)和Stargardt病都非常有用。
  • Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
    申请人:Acucela Inc.
    公开号:US20150166494A1
    公开(公告)日:2015-06-18
    The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.
    本发明涉及一般用于治疗神经退行性疾病和紊乱的组合物和方法,特别是用于治疗眼科疾病和紊乱。本文提供了包括但不限于苯乙烯衍生物化合物和含有这些化合物的组合物,这些化合物可用于治疗和预防眼科疾病和紊乱,包括老年性黄斑变性(AMD)和Stargardt病。
  • Photoresist compositions and use of same
    申请人:Shipley Company LLC
    公开号:EP1143300A1
    公开(公告)日:2001-10-10
    Compositions and methods of the invention provide for a controlled flow of resist into device contact (via) holes during a post-exposure, post-development hard-bake step. Resists of the invention are positive-acting and contain one or more components that are preferably substantially stable (i.e. no substantial crosslinking) during: 1) soft-bake, pre-exposure thermal treatment to remove solvent carrier of the applied resist, and 2) post-exposure, pre-development thermal treatment to promote or enhance the acid-promoted reaction in exposed regions (typically a de-blocking reaction). However, resists of the invention will crosslink during a post-development more stringent thermal treatment (thermal flow hard-bake step).
    本发明的组合物和方法可在曝光后、显影后的硬烘烤步骤中,使光刻胶受控地流入器件接触(通孔)孔中。本发明的光刻胶是正向作用的,含有一种或多种成分,这些成分在以下过程中最好是基本稳定的(即没有实质性的交联):1) 软烘烤、曝光前热处理,以去除所涂抗蚀剂的溶剂载体;以及 2) 曝光后、显影前热处理,以促进或增强曝光区域的酸促进反应(通常是去阻塞反应)。然而,本发明的抗蚀剂会在显影后更严格的热处理(热流硬烘烤步骤)过程中发生交联。
查看更多